Brief: vTv Therapeutics Reports Net Loss Of $0.04 Per Basic Share
15/08/2022 23:30
Aug 15 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS INC - QTRLY NET LOSS ATTRIBUTABLE TO VTV
SHAREHOLDERS $0.04 PER BASIC SHARE
Source text for Eikon: [https://bit.ly/3SQDjhm]
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)